Page 2 - மெர்க் உலகளாவிய ஆரோக்கியம் கண்டுபிடிப்பு நிதி News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Strata Oncology sets Michigan record for biotech capital raise
crainsdetroit.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from crainsdetroit.com Daily Mail and Mail on Sunday newspapers.
PathAI enters into clinical diagnostics through acquisition of Poplar Healthcare Management
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
PathAI acquires part of Poplar pathology lab
modernhealthcare.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernhealthcare.com Daily Mail and Mail on Sunday newspapers.
Q2 wraps up with more than $6 2 billion in digital health investments
mobihealthnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mobihealthnews.com Daily Mail and Mail on Sunday newspapers.
Vancouver, Wash. biotech company Absci files to go public
July 1, 2021 at 8:36 am
Absci CEO and founder Sean McClain. (Absci Photo)
Absci, a Vancouver, Wash.-based company developing technologies to accelerate the process of drug discovery, announced today that it plans to go public via an IPO. The company’s platform is built to design and generate protein-based drug candidates and help screen them for optimal functioning.
The announcement follows a string of acquisitions and funding rounds for the company. This month the company acquired the synthetic biology company Totient, following its January acquisition of Denovium, a small deep learning startup capable of analyzing the function and behavior of proteins.